Atlas Capital Advisors LLC Amarin Corp Plcuk Transaction History

Atlas Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$1.19 - $2.19 $595 - $1,095	-500 Reduced 50.0%	500 $750,000
Q3 2022 Nov 08, 2022	SELL	$1.09 - $1.67 $545 - $835	-500 Reduced 33.33%	1,000 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $6,060 - $7,964	1,500 New	1,500 $7,000
Q3 2020 Oct 23, 2020	SELL	$3.64 - $7.76 $5,460 - $11,640	-1,500 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$4.0 - $21.53 $2,000 - $10,765	500 Added 50.0%	1,500 $6,000
Q2 2019 Jul 25, 2019	BUY	$16.27 - $20.51 $16,270 - $20,510	1,000 New	1,000 $0

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.